Lansinoh Laboratories Benelux SA

2.9 FTE

Lansinoh Laboratories Benelux reported total assets of €3.11m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jun 2026), with 2.9 full-time equivalents.

By total assets for 2025, Lansinoh Laboratories Benelux ranks in the top half of the 970 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0630.939.468 · VAT BE0630939468
2200 Herentals
active in Wholesale of pharmaceutical and medical goods (NACE 46460)
operating since 29 May 2015 (≈ 11 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Lansinoh Laboratories Benelux shows with a free account.

See the score
Profile
SA Micro · 2.9 FTE since 2015
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result472,688 €
Equity€1.58m
Cash€1.87m
EBITDA661,635 €
Total assets€3.11m
Headcount (avg FTE)2.9
The line marks its sector median: 46.0% (567 companies).

Change 2022 → 2025: Equity -19 % Total assets +11 % Headcount (avg FTE) +26 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Lansinoh Laboratories Benelux's annual accounts

20252024202320222021
Net result472,688 €
Equity€1.58m
Cash€1.87m
EBITDA661,635 €
Total assets€3.11m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 17 Jun 2026
  • Year ended 31 Dec 2024filed on 02 Jul 2025
  • Year ended 31 Dec 2023filed on 15 Jul 2024
  • Year ended 31 Dec 2022filed on 27 Jul 2023
  • Year ended 31 Dec 2021filed on 21 Sep 2022

Lansinoh Laboratories Benelux's financial analysis

Management and control of Lansinoh Laboratories Benelux

3 active director(s) in the register.

Lansinoh Laboratories Benelux's shareholders and holdings →

Lansinoh Laboratories Benelux's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0630.939.468
VAT number
BE0630939468
Peppol
Registered · 0208:0630939468 · as of 12 Nov 2026
Legal form
SA
Incorporated
29 May 2015
Registered office
2200 Herentals
Size
Micro · 2.9 FTE
Latest accounts
2025 · filed on 17 Jun 2026
Activity
Wholesale of pharmaceutical and medical goods (NACE 46460)

Lansinoh Laboratories Benelux (SA) has been based in Herentals since 2015, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 472,688 € and equity of €1.58m; its revenue is not published. With 2.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 50.9%, above the median of its sector (46.0%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Lansinoh Laboratories Benelux

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Lansinoh Laboratories Benelux

What is the revenue of Lansinoh Laboratories Benelux?

Lansinoh Laboratories Benelux files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Lansinoh Laboratories Benelux?

In Belgium, the VAT number is the company number prefixed with BE: BE0630939468 for Lansinoh Laboratories Benelux, if the company is VAT-registered. Its company number (CBE) is 0630.939.468.

Where is the registered office of Lansinoh Laboratories Benelux?

According to the CBE register, the registered office of Lansinoh Laboratories Benelux is in 2200 Herentals.

What is the equity of Lansinoh Laboratories Benelux?

At the close of the 2025 financial year, the equity of Lansinoh Laboratories Benelux amounts to 1,580,790 €, a solvency of 50.9% of total assets.

How many people work at Lansinoh Laboratories Benelux?

2.9 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Lansinoh Laboratories Benelux?

The register lists 3 active mandates at Lansinoh Laboratories Benelux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Lansinoh Laboratories Benelux within its sector?

By total assets for 2025, Lansinoh Laboratories Benelux ranks in the top half of the 970 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.

Idonis

The full file of Lansinoh Laboratories Benelux

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 12 Aug 2026

No credit card, no commitment.

What each plan unlocks →